Clinical samples analyzed in this study confirmed these findings via immunohistochemistry, revealing significantly higher expression of HNRNPA2B1 and HNRNPC in the eutopic endometrium of fertile women compared to ovarian EMS patients. This evidence concerns the gene HNRNPC and eosinophilia-myalgia syndrome.